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Abstract: Being able to quantify ichthyotoxic metabolites from microalgae allows for the determination
of ecologically-relevant concentrations that can be simulated in laboratory experiments, as well as
to investigate bioaccumulation and degradation. Here, the ichthyotoxin karmitoxin, produced by
Karlodinium armiger, was quantified in laboratory-grown cultures using high-performance liquid
chromatography (HPLC) coupled to electrospray ionisation high-resolution time-of-flight mass
spectrometry (HRMS). Prior to the quantification of karmitoxin, a standard of karmitoxin was
purified from K. armiger cultures (80 L). The standard was quantified by fluorescent derivatisation
using Waters AccQ-Fluor reagent and derivatised fumonisin B1 and fumonisin B2 as standards,
as each contain a primary amine. Various sample preparation methods for whole culture samples
were assessed, including six different solid phase extraction substrates. During analysis of culture
samples, MS source conditions were monitored with chloramphenicol and valinomycin as external
standards over prolonged injection sequences (>12 h) and karmitoxin concentrations were determined
using the response factor of a closely eluting iturin A2 internal standard. Using this method the
limit of quantification was 0.11 µg·mL−1, and the limit of detection was found to be 0.03 µg·mL−1.
Matrix effects were determined with the use of K. armiger cultures grown with 13C-labelled bicarbonate
as the primary carbon source.
Keywords: harmful algal bloom; ichthyotoxic; karlotoxin; amphidinol; polyether; polyketide;
quantify; quantitation
1. Introduction
Harmful algal blooms (HAB) are a global phenomenon with an apparent increasing
occurrence [1–3]. Their adverse effects to coastal communities, public health, tourism, and fisheries
can be devastating and have large economic implications [4]. In addition to causing adverse effects
on people exposed to toxins accumulated in shellfish [5,6], HAB are also responsible for wide spread
mortalities in a range of marine and marine-associated species [7–10], these events can indirectly affect
human populations via economic loss in farmed fish, as well as through the death of fish and shellfish
in wild fisheries [4].
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Although microalgae are known producers of toxins that can affect humans, such as saxitoxin
responsible for paralytic shellfish poisoning [11–13], okadaic acid responsible for diarrhetic shellfish
poisoning [14,15], and domoic acid responsible amnesic shellfish poisoning [16], the ichthyotoxic
metabolites and mechanisms responsible for fish kills during HAB events are not so well understood [17].
Recently, however, the mode of action for karlotoxin 8, one of many structurally-related metabolites
produced by dinoflagellates, has been investigated by NMR and suggests that these toxins bind to
cell membranes in a hairpin-type arrangement, causing lysis [18]. It is suspected that the variation in
the intramolecular polarity of these metabolites, having both polar and apolar regions, assists in their
toxicity [18]. It may also explain the characteristic of these medium polarity metabolites being retained
on polytetrafluoroethylene (PTFE) filters as well as on glass fibre filters [19].
For common algal toxins which affect humans there are numerous quantitative and
semi-quantitative methods, however, for ichthyotoxic metabolites there are few [19,20], with the
exception of ichthyotoxins, which also effect humans. This is certainly the case for the brevetoxin
and ciguatoxin class of neurotoxins, which are routinely monitored with enzyme-linked immunosorbent
assays and high-performance liquid chromatography (HPLC) coupled to tandem mass spectrometry
(MS/MS) [21–24]. For the linear superchain polyether class of microalgae metabolites, such as karlotoxin
2, only low-resolution MS methods have been reported for laboratory-grown cultures [19]. There are
many challenges in working with these compounds, in addition to the lack of commercially-available
standards, such as difficulties in strain cultivation and harvesting on large scales, low biological
production of the ichthyotoxins, compound degradation, and biomass/media split of ichthyotoxins.
MS/MS analysis on triple quadrupole mass analysers (QqQ) is the dominant trace quantification
technique due to the high sensitivity and selectivity in selected reaction monitoring (SRM, also known
as multiple reaction monitoring, MRM). However it has been shown that accurate mass quadrupole
time-of-flight MS (QTOF-MS) instruments can provide selectivity comparable to precursor-product
ions and ratios from SRM experiments [25,26]. In addition to this, although the sensitivity of
QTOF-MS instruments may not match that of QqQ instruments, they can come close and, additionally,
they allow both targeted identification as well as screening for unknowns, which can be beneficial when
analysing environmental samples, detecting metabolites of biotransformation, as well as recursive
data-analysis [27–29].
The dinoflagellate Karlodinium armiger produces karmitoxin [30], an ichthyotoxic metabolite
structurally related to the karlotoxins, amphidinols, and others (Table S1) [31–55]. Presented here is
a method for the quantitative analysis of karmitoxin in laboratory-grown cultures of K. armiger using
iturin A2 as an internal standard by HPLC-QTOF-MS. The method developed assessed nine different
sample preparation procedures, including six solid phase extraction (SPE) substrates, and source
conditions were monitored with external reference standards, valinomycin and chloramphenicol.
To avoid compound loss in the sample preparation procedures, whole culture subsamples were
extracted, eliminating the possibility of toxin transfer to the aqueous phase by cell lysis during
centrifugation, and also capturing any allelopathic proportion of karmitoxin. Recovery and matrix
effects were also assessed by standard addition to 13C-labelled cultures. A quantitative standard of
karmitoxin was purified from laboratory-grown cultures of K. armiger and quantified by fluorescent
derivatisation in reference to a calibration curve of derivatised fumonisin B1 and fumonisin B2.
Other studies have shown that high growth rates of K. armiger can be achieved in mixotrophic cultures,
however, it is not known how toxin production changes in these mixotrophic environments [56].
The relationship of karmitoxin concentration and the growth phase of K. armiger was investigated,
as well as a comparison of karmitoxin concentration in cultures grown under phototropic conditions
with cultures grown under mixotrophic conditions.
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2. Results and Discussion
2.1. Method Development
Of the nine different sample preparation methods, it was found that lyophilisation resulted in the
greatest integrated peak area relative to extraction volume and also had the lowest standard deviation
of all sample preparation methods (Figure 1).
Mar. Drugs 2017, 15, 278  3 of 13 
 
2. Results and Discussion 
2.1. Method Development 
Of the nine different sample preparation methods, it was found that lyophilisation resulted in 
the greatest integrated peak area relative to extraction volume and also had the lowest standard 
deviation of all sample preparation methods (Figure 1). 
 
Figure 1. Performance of sample preparation procedures. Integrated peak areas of karmitoxin (peak 
area of the monoisotopic isotopomer from the most abundant adduct, [M + H]+), from 
HPLC-QTOF-MS analysis of different sample preparation methods and relative standard deviations 
of the five replicates (three replicates for solid phase extraction methods, indicated collectively with 
green bars) from each sample preparation procedures. 
Nitrogen drying and liquid/liquid sample preparation methods both had poor repeatability and 
relatively low relative recovery. In terms of sample preparation performance, Strata-X SPE had the 
greatest relative recovery of all SPE methods and one of the lowest relative standard deviation 
(RSD). Among all sample preparation methods lyophilisation had the greatest relative recovery, as 
well as the lowest RSD, however, due to concerns about matrix effects, an SPE method was also 
utilized in further analysis. The two methods with the greatest relative recoveries, lyophilisation and 
Strata-X SPE, were chosen as the preparation methods for laboratory experiments.  
Monitoring source conditions, in terms of adduct pattern stability of external standards over 
time, during analysis of samples prepared using lyophilisation and Strata-X, it was found that there 
was significantly greater stability in the adduct formation of external standards during the analysis 
of samples prepared using Strata-X. This stability was likely due to the better removal of salts. 
The RSD of the combined peak areas of all monitored ions in chloramphenicol was found to be 
30% during the analysis of samples prepared using lyophilisation, compared to 4% during samples 
prepared using Strata-X. This indicated that the Strata-X method of sample preparation produced 
more stability in adduct formation. A similar trend was seen, though to a lesser extent, in the 
combined peak areas of monitored ions formed by valinomycin. During the analysis of samples 
prepared by lyophilisation the RSD of the valinomycin external standard was found to be 39%, 
whereas it was 22% during the analysis of samples prepared with Strata-X (Figure 2). The variation 
in the individual adducts of the lyophilisation samples were even more pronounced, particularly 
with the sodium adduct, which initially made up 87% of the total combined adduct area, and then 
dropped to 29% before then increasing to 67%. This dramatic change in total relative adduct 
composition was not seen in the samples from Strata-X preparation. 
These results showed that sample preparation via lyophilisation resulted in significantly more 
instability in ion source conditions compared to SPE Strata-X and, therefore, the SPE method was 
chosen for quantification experiments. 
Figure 1. Performance of sample preparation procedures. Integrated peak areas of karmitoxin (peak area
of the monoisotopic isotopomer from the most abundant adduct, [M + H]+), from HPLC-QTOF-MS
analysis of different sample preparation methods and relative standard deviations of the five replicates
(three replicates for solid phase extraction methods, indicated collectively with green bars) from each
sample preparation procedures.
Nitrogen drying and liquid/liquid sample preparation methods both had poor repeat bility and
relatively low relative recovery. In terms of sample preparation perfo mance, Strata-X SPE had the
greatest relative recovery of all SPE methods and one of the lowest relative standard deviation (RSD).
Among all sample preparation methods lyophilisation had the greatest relative recovery, as well as
the lowest RSD, however, due to concerns about matrix effects, an SPE method was also utilized in
further analysis. The two methods with the greatest relative recoveries, lyophilisation and Strata-X
SPE, were chosen as the preparation methods for laboratory experiments.
Monitoring source conditions, in terms of adduct pattern stability of external standards over time,
during analysis of samples prepared using lyophilisation and Strata-X, it was found that there was
significantly greater stability in the adduct ormation of exter al standards during the analysis of
samples prepared using Strata-X. This stability was likely due to the better removal of salts.
The RSD of the combined peak areas of all monitored ions in chloramphenicol was found to be
30% during the analysis of samples prepared using lyophilisation, compared to 4% during samples
prepared using Strata-X. This indicated that the Strata-X method of sample preparation produced more
stability in adduct formation. A similar trend was seen, though to a lesser extent, in the combined
peak areas of monitored ions formed by valinomycin. During the analysis of samples prepared by
lyophilisation the RSD of the valinomycin external standard was found to be 39%, whereas it was
22% uring the analysis f samples prepared with Strata-X (Figure 2). The variation in the individual
addu ts of the lyophilisation samples were even more pronou ced, particularly with the sodium
adduct, w ich initially made up 87% of the total combined adduct area, and then dropped to 29%
before then increasing to 67%. This dramatic change in total relative adduct composition was not seen
in the samples from Strata-X preparation.
These results showed that sample preparation via lyophilisation resulted in significantly more
instability in ion source conditions compared to SPE Strata-X and, therefore, the SPE method was
chosen for quantification experiments.
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Figure 2. Combined integrated peak areas of monitored adducts for each of the external standards:
chloramphenicol ([M + H]+, [M + Na]+, [3M + Fe(II)]2+, [2M − 2H + Fe(III)]+) and valinomycin
([M + H]+, [M + NH4]+, [M + Na]+), monitored during the HPLC-QTOF-MS analysis of samples
prepared by lyophilisation, and by solid phase extraction Strata-X.
2.2. Quantification
The fragmentation of karmitoxin was investigated on an Agilent HPLC-QTOF system. This system
was utilized to investigate the fragmentation of karmitoxin due to its transferability of ion source
parameters to the available Agilent UHPLC-QqQ for potential method transfer. The MS/MS
fragmentation of karmitoxin showed very limited fragmentation occurring from 10 to 60 CeV,
while above 60 CeV extensive fragmentation was observed, with both (i) very poor product ion yields
(<5%) (Figure 3), and (ii) not very specific fragment ions (water loss ions), the most significant of which
was the [M − 3(H2O) + H]+ fragmentati ion with a 4.8% yield at 60 CeV (Figure 3). In most MS/MS
spectrum with the greatest i dividual product ion yields, due to poor fragme tation, the precursor ion
was the most abundant ion. Evaluation of the signal-to-noise ratio (S/N) in six samples by M MS on
an Agilent UHPLC-QqQ instrument, using this transition in comparison to the protonated adduct on the
Bruker HPLC-QTOF-MS system, showed an average 7.6-fold lower S/N, leading to the continued use
of the high-resolution instrument. The Bruker HPLC-QTOF-MS was utilized throughout the remainder
of the study due to more favourable ionization and adduct formation.
The concentration of karmitoxin in laboratory grown cultures was assessed over 23 days, up to
and including the stationary phase, to determine the relationship between kar itoxin and the growth
phase (Figures 4 and 5) nd to etermine the effect of mixotrophy on kar itoxin production (Figure 5).
The samples taken were quantified ag inst a calibr tion curv of k rmitoxin in methanol (MeOH) and
values adjusted based on a two-day calculated recovery from the standard addition to 13C-labelled
culture samples. The calculated apparent recovery was 57% with a RSD of 20%. The high RSD was
mostly influenced by the lowest level (level 1: 0.06 µg·mL−1). Excluding the lowest level from the
calculation resulted in a RSD of 9.3%, however, as two of the 126 samples had concentrations which fell
between level 1 and level 2, all levels were included in calculations. The calibration curve had linearity
with an R2 value of 0.972 (Figure S1). Despite testing a range of different stationary phases, and utilizing
the solid substrate with the greatest relative recovery in method development, recovery was still low,
albeit reproducible. A definitive cause of the low recov ry cannot be made, however, hi class of
metabolites as previously been desc ibed as being “s icky” [57] wit the ability o adhere to a range
of substrates including a olar polytetrafluoroethylene (PTFE) filters and polar glass fibre filters [19].
These unusual characteristics can perhaps be attributed to the intramolecular polarity variation of
these metabolites, having both significant polar and apolar regions.
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the Agilent QTOF system. The red line indicates a 5% individual product ion yield. The average mass
accuracy of the precursor ion in this dataset was 2.1 ppm. The ions with the highest individual product
ion yields in the 60 and 80 CeV spectra were products of the consecutive neutral loss of ater, and each
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between fragmentation spectra was the 1070.62 ion, likely arising from the loss of the apolar arm with
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Figure 4. K. armiger culture grown in ammonium-substituted f/2 media: a comparison of culture
cell concentration (cells· L−1) to the concentration of karmitoxin (µg·mL−1). The concentration of
karmitoxin c rrelated with cell concentration, a linear regression of karmitoxin per cel had an R2 value
of 0.84 cross all growth phases (Figure S2). The displayed standard deviation for each sample day is
the standard deviation across all of the biological replicates. The average relative standard deviation
across all sample points was 20%.
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Figure 5. K. armiger culture grown in f/2 media in the presence of Rhodomonas salina as a food source:
a comparison of cell concentration (cells·mL−1) to the concentration of karmitoxin (µg·mL−1). As with
the cultures grown on ammonium-substituted f/2 media, the concentration of karmitoxin correlated
with cell concentration, a linear regression of karmitoxin per cell had an R2 value of 0.93 across all
growth phases (Figure S3). The stationary growth phase appeared to begin at day 8, two days later
than that of K. armiger grown in ammonium-substituted f/2 media. The displayed standard deviation
for each sample day is the standard deviation across all of the biological replicates. The average relative
standard deviation across all biological replicates was 10%.
Across all growth phases there was a proporti nal elationship between karmitoxin concentration
and cell count in both growth mediums (Figures S2 and S3). The average concentration of karmitoxin
in Rhodomonas salina fed K. armiger was 8.8 pg·cell−1 and had a RSD of 9.1%. The average concentration
of karmitoxin for K. armige grown in ammonium sub titu d f/2 media was 7.1 pg·cell−1 and had
a RSD of 11%. Using ANOVA statistical analysis it was determined that this difference in karmitoxin
production between the two growth media was statistically significant (p < 0.0001) (Table S2), however,
it is possible th this observed 23% increase in karmit xin conc ntration i mixotrophic cultures
is associated with increased nutrition from R. salina rather than being a predator-prey induced
phenomenon. This proportional production of karmitoxin in relationship to cell concentration seen
here with K. armi er is in contrast t a semi-quantification study on another ichthyotoxic microalgae,
the haptophyte Prymnesium parvum, in relation to the ichthyotoxins prymnesin 1 and 2, which found
that the concentration of these large polyketides was not directly proportional to cell concentration [20].
Using Strata-X for sample preparation, the matrix effect was very low (106%, RSD 13%). The limit
of quantification (LOQ) was found to be 0.11 µg·mL−1, and the limit of detection (LOD) was
0.03 µg·mL−1. This method could be adjusted to obtain a lower LOQ, such as increasing sample
concentration, however for the purposes of this study, a lower LOQ was not necessary with cell
concentrations above 10,000 cell·mL−1.
3. Materials and Methods
3.1. Chemicals, Standards and Materials
All solvents used for sample preparation were of HPLC grade and purchased from Sigma-Aldrich
(Schnelldorf, Germany). All solvents used for sample analysis, water (H2O), methanol (MeOH),
and acetonitrile (ACN), were of LCMS grade and purchased from Sigma-Aldrich. Formic acid
(≥96%) was purchased from Thermo Fisher Scientific (Waltham, MA, USA). H2O for SPE was
purified on a Milli-Q system (Merck Millipore, Billerica, MA, USA). Iturin A2 (>95%) was purchased
from Sigma-Aldrich and the stock solution (20 µg·mL−1) was prepared in HPLC grade MeOH.
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Sodium bicarbonate (NaHCO3), 98% 13C-labelled, was purchased from Sigma-Aldrich. Fluorescence
derivatisation was achieved with AccQ-Fluor reagent WAT052880 (Waters; Milford, MA, USA).
The mixture of fumonisin B1 (49.9 µg·mL−1) and fumonisin B2 (50.6 µg·mL−1) in H2O/ACN (1:1, v/v)
was purchased from Romer Labs (Tulln, Austria). External standards valinomycin and chloramphenicol
were purchased from Sigma-Aldrich. Five different, 3 mL, 30 mg, SPE cartridges, Strata-X, Strata-SCX,
Strata-WCX, Strata-SAX, Strata-MAX, were purchased from Phenomenex (Torrance, CA, USA).
Three millilitre, 30 mg Oasis-HLB SPE cartridges were purchased from Waters.
3.2. Algal Cultures
The K. armiger, strain K-0668, and R. salina, strain K-1487, were acquired from the Scandinavian
Culture Collection for Algae and Protozoa (Marine Biological Section, University of Copenhagen,
Copenhagen, Denmark). The R. salina cultures were maintained in f/2 media and K. armiger cultures
were maintained in modified f/2 media with NO3− substituted with 50 µM NH4+ both prepared using
pasteurised (95 ◦C, 1.5 h) seawater at 30 practical salinity units with aeration and a light-dark cycle of
14:10 h. NaHCO3 was added to media, at a final concentration of 0.5 mM, to counter losses from the
heat treatment of the seawater. Aeration was supplied to avoid elevated pH in the cultures due to high
rates of photosynthesis. Cultures were grown at a constant temperature of 15 ◦C with an irradiance of
150 µmol photons m−2·s−1. Cultures with 13C enrichment were grown under the same conditions with
the exception of the carbon source and aeration. In 13C-enriched cultures, aeration was removed and
a total of 2.6 mM 13C-labelled NaHCO3 was added in multiple steps to achieve 52% 13C incorporation
(determined by HPLC-QTOF-MS). In the absence of aeration, the pH of 13C-enriched cultures was
adjusted as needed with 1 M HCl solution. Cultures utilized in karmitoxin standard preparation
were harvested during the stationary phase, which was determined by cell count. Cell densities were
determined during growth by light microscope.
3.3. Karmitoxin Standard Quantification
Multiple cultures of K. armiger (total 80 L) were extracted utilizing a method previously
described [30], in order to acquire a purified sample of karmitoxin to be used for quantification.
The karmitoxin standard was compared in accurate mass (<2 ppm) and retention time to
a previously-isolated and structurally-elucidated (by nuclear magnetic resonance spectroscopy)
sample [30], which was obtained using the same purification protocol.
The concentration of the isolated toxin was determined by an average of two external calibration
curves using a certified reference standard mixture of fumonisin B1 and fumonisin B2 (both containing
a primary amine, as with karmitoxin), derivatised with AccQ-Fluor reagent. Fumonisin mixture, 20 µL,
was combined with 140 µL borate buffer in a 300 µL glass vial. The solution was briefly vortexed and
40 µL of reconstituted AccQ-Fluor reagent (3.0 µg·mL−1, in ACN) was added to the vial, which was
homogenised immediately and placed on a heating block at 55 ◦C for 10 min, resulting in a derivatised
fumonisin stock solution (4.99 µg·mL−1). Five levels of the stock solution were prepared in triplicate,
applying serial dilutions with borate buffer resulting in the following concentrations: 0.07, 0.15, 0.31,
0.62, and 1.25 µg·mL−1. Using an equivalent derivatisation procedure, 10 µL of karmitoxin stock
solution was derivatised in four replicates. These samples were submitted to HPLC-fluorescence
analysis, with 5 µL injection volumes (Figures S4 and S5).
Derivatised samples were analysed on an Ultimate 3000 UHPLC system (Dionex; Sunnyvale, CA,
USA) coupled to an Agilent 1100 Fluorescence detector (Agilent Technologies; Santa Clara, CA, USA)
operating in λ excitation 250 nm and emission 395 nm. Chromatographic separation was achieved
on a Phenomenex Kinetex reversed phase column (2.6 µm, C18, 100 Å, 100 mm × 2.1 mm). A linear
gradient elution was used for separation at a constant flow rate of 400 µL·min−1, using two eluents,
eluent A: H2O, and eluent B: ACN, both of which contained 20 mM formic acid. The gradient started
at 10% B and increased to 80% B over 12 min, then to 100% B over 0.5 min, and was held at 100% B for
1.5 min before being re-equilibrated for subsequent injections.
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3.4. Culture Sampling
To determine the best method for sampling preparation, nine different culture sampling methods
were assessed; whole culture drying (detailed in (1) below), liquid/liquid extraction (2), lyophilisation
(3), and six different SPE substrates (4). For each method a subsample (3 mL) from a larger K. armiger
culture (1 L) in the exponential growth phase, determined by cell concentration derived from light
microscope counts, was extracted.
(1) The culture subsample (3 mL) was directly dried under a N2 stream (25 ◦C). The dried sample was
dissolved in MeOH (1 mL) and placed in an ultrasonic bath (5 min). A subsample (800 µL) was
transferred to an Eppendorf tube (1.5 mL) and centrifuged (10 min, 9000 RCF). The supernatant
(500 µL) was transferred to a glass HPLC vial for analysis by LC-MS. The method was performed
in five replicates.
(2) Ethlyacetate (EtOAc) (3 mL) was added to the culture subsample (3 mL) and placed in
an ultrasonic bath (5 min). The EtOAc layer (2.8 mL) was dried under a N2 stream (25 ◦C).
The dried sample was dissolved in MeOH (1 mL) and placed in an ultrasonic bath (5 min).
A subsample (800 µL) was transferred to an Eppendorf tube (1.5 mL) and centrifuged (10 min,
9000 RCF). The supernatant (500 µL) was transferred to a glass HPLC vial for analysis by LC-MS.
The method was performed in five replicates.
(3) The culture subsample (3 mL) was frozen to −80 ◦C and then lyophilised. The lyophilised
sample was dissolved in MeOH (2 mL) and placed in an ultrasonic bath (5 min). A subsample
(800 µL) was transferred to an Eppendorf tube (1.5 mL) and centrifuged (10 min, 9000 RCF).
The supernatant (500 µL) was transferred to a glass HPLC vial for analysis by LC-MS. The method
was performed in five replicates.
(4) The culture subsample (3 mL) was directly loaded onto a conditioned (MeOH, 2 mL) and
equilibrated (Milli-Q H2O, 2 mL) SPE cartridge (30 mg). This was followed by a salt removal
washing step (H2O, 3 mL) and flushing with air. Sample collection then followed with elution
(MeOH, 1 mL) and a final flushing with air. A subsample (500 µL) was transferred to a glass
HPLC vial for analysis. The method was performed in triplicates on six different solid phases:
Strata-X, Strata-SCX, Strata-WCX, Strata-SAX, Strata-MAX, and Oasis-HLB.
Samples from each of the methods were submitted to HPLC-QTOF-MS analysis, using 2 µL
injection volumes. The two most effective sampling methods, lyophilisation and Strata-X SPE,
were investigated for their robustness over extended sample sequences and multiple injections to
determine their appropriateness for quantitative experiments, especially targeting fouling on the ion
source by salts. A 1 L culture of K. armiger was grown in triplicate, in ammonium-replaced f/2 media.
Six 3 mL culture samples were taken from each of the cultures at specific time intervals (0, 2, 4, 8, 12,
and 24 h). For each of the time intervals, half of the culture samples were prepared using one of the
two sample preparation methods.
Samples from one method were analysed separately from the other on consecutive days.
Prior to the analysis of samples for each sample preparation procedure the source of the MS was
thoroughly cleaned. Source conditions, in regards to ionization repeatability, were monitored using
external standards valinomycin and chloramphenicol, routinely injected as a mixture after every
six sample injections. Multiple ions formed by each of the standards were monitored over time
to determine changes in the proportion of adduct formation. These ions were chloramphenicol:
323.0196 ([M + H]+), 345.0046 ([M + Na]+), 509.9878 ([3M + Fe(II)]2+), 695.9481 ([2M − 2H + Fe(III)]+);
and valinomycin: 1111.6384 ([M + H]+), 1128.6650 ([M + NH4]+), 1133.6204 ([M + Na]+). Ions of
chloramphenicol were integrated with an m/z tolerance of 0.002 Da, and ions of valinomycin
were integrated with an m/z tolerance of 0.005 Da, each resulting in a minimum mass accuracy
of 5 ppm. The mixture of chloramphenicol and valinomycin was chosen as an external standard
due to the two compounds’ range of characteristics: chloramphenicol, a small (323.13 g·mol−1)
early-eluting (4.24 min), nitro-containing aromatic, and valinomycin, a large (1111.32 g·mol−1),
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late-eluting (11.64 min), macrocyclic peptide. Of the two methods SPE sample preparation with
Strata-X was found to be superior; this method was selected for quantitative experiments.
3.5. Culture Quantification
Two treatments were applied to 1 L cultures of K. armiger in triplicate, one of the triplicates was
grown with f/2 media and fed R. salina, and the other was grown in ammonium replaced f/2 media.
Triplicate 3 mL culture samples were taken from each of the cultures at specific time intervals (1, 3,
5, 7, 9, 16, and 23 days), and using Strata-X SPE sample preparation. Iturin A2 was added to each of
the samples as an internal standard. The samples for each of the methods were then submitted to
HPLC-QTOF-MS for analysis, using 2 µL injection volumes.
The concentration of karmitoxin in the samples from the experimental cultures was quantified
using a non-weighted linear external calibration performed in triplicate at seven levels. The stock
solution of karmitoxin (19.40 µg·mL−1, determined by AccQ-Flour derivatisation) was diluted to
appropriate concentrations in MeOH together with the internal standard, iturin A2. This resulted in
an external calibration curve of karmitoxin with the following concentrations: 0.00, 0.06, 0.12, 0.24, 0.60,
and 0.80 µg·mL−1. LOD was calculated as the standard error divided by the correlation coefficient
multiplied by 3 and the LOQ was calculated as the standard error divided by the correlation coefficient
multiplied by 10. Recovery was determined on two days by spiking karmitoxin in Milli-Q H2O before
the SPE sample preparation procedure at six levels (0.00, 0.06, 0.12, 0.24, 0.60, and 0.80 µg·mL−1)
in triplicate. Matrix effects were determined by spiking 13C incorporated cultures of K. armiger
with karmitoxin after the sample preparation procedure, also in triplicate at the same six levels.
There was no detection of unlabelled karmitoxin within 13C-labelled culture samples with no spiked
karmitoxin. Recovery and matrix effects were determined in relation to the internal standard iturin A2.
Integrated peak area of iturin A2 was calculated as a sum of three adducts (m/z 1043.5520, [M + H]+;
m/z 1065.5340, [M + Na]+; m/z 522.2797, [M + 2H]2+) and the integrated peak area of karmitoxin
was calculated as the sum of three adducts (m/z 1386.8872, [M + H]+; m/z 1387.8906, 13C-[M + H]+;
m/z 704.9382, [M + H + Na]2+). Integration of all selected ions was achieved with a mass accuracy
of <5 ppm, using ion specific m/z tolerances. Iturin A2 was selected as an internal standard for its
similarity in monoisotopic ion mass and retention time to karmitoxin, m/z of 1043.5520 and 1386.8872,
and retention times of 5.70 and 5.65 min, respectively (Figure S6).
3.6. Liquid Chromatography—High Resolution Mass Spectrometry
Culture samples were analysed by HPLC-QTOF-MS. A Dionex Ultimate 3000 with a diode array
detector (DAD) equipped with a Phenomenex Kinetex column (2.6 µm, C18, 100 Å, 100 mm × 2.1 mm)
was used for chromatographic separation and maintained at 40 ◦C. Two eluents were used: eluent A
(H2O, 20 mM formic acid), and eluent B (ACN, 20 mM formic acid). Eluents were used in a gradient
starting with 10–70% eluent B over 6.7 min, followed by 70–100% eluent B over 1.3 min, then held at
100% eluent B for 3 min. All analysis was carried out at a constant flow rate of 400 µL·min−1.
The HPLC system was coupled to a Maxis QTOF MS with electrospray ionisation (ESI)
(Bruker Daltonics, Bremen, Germany). Analysis was carried out in positive ESI. The scan range
was m/z 300–2500 with two scans per second. The capillary voltage was set to 4500 V, the nebuliser
gas was at 1.8 bar, and the dry gas was 200 ◦C at a flow rate of 10 L·min−1.
Prior to the analysis of samples, the QTOF-MS was calibrated using a sodium formate calibrant
with an accepted calibration being <1 ppm. In addition, all data files were recalibrated with an internal
standard of sodium formate injected prior to initial sample elution for each sample.
3.7. Liquid Chromatography—Tandem Mass Spectrometry
The fragmentation of karmitoxin was investigated for potential quantification by SRM,
using an Agilent Infinity 1290 UHPLC system (Agilent Technologies, Santa Clara, CA, USA) coupled to
an Agilent 6545 QTOF MS and a similar UHPLC coupled to an Agilent 6490 Triple QqQ MS. A range of
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collision energies were tested (20, 40, 50, 60, 80, 100, and 150 CeV) to determine the optimal fragment
ion yields.
4. Conclusions
Lyophilisation initially resulted in the lowest standard deviation and greatest intensity of all
tested sample preparation methods. Over long injections sequences, however, samples prepared using
this procedure were found to have compromised adduct formation stability. When applying the same
injection sequence to SPE Strata-X prepared samples it was found to have a much more stable adduct
formation and is therefore more suitable for quantification.
In a semi-quantitative analysis of the SPE sample preparation methods, based on the integrated
peak areas, it appeared that all SPE methods had either similar or lower recoveries compared to the
Strata-X stationary phase, assuming similar matrix effects. Although the apparent recovery of 57% for
Strata-X is low, it was importantly found to be reproducible, particularly above the lowest spiked level,
with a RSD of recovery for these levels of 9.3%. The related metabolites, the karlotoxins, have been
described as “sticky” compounds [57], with the ability to be retained on many different substrates [19].
It is possible that these unusual properties of this family of metabolites contributed to the low recovery
seen in our sample preparation procedure.
Analysis of the fragmentation of karmitoxin for QqQ SRM quantification found that this
metabolite had very poor fragmentation characteristics, producing low individual product ion yields
and nonspecific fragmentation ions. This is thought to be due to this metabolites long, flexible,
uninterrupted carbon backbone, and may be a characteristic of other amphidinol-like metabolites.
Analysis of a few samples found that QTOF-based analysis provided higher S/N sensitivity compared
to QqQ SRM analysis, due to these poor fragmentation characteristics. Altogether this report represents
the first HRMS quantitative recovery experiment on a metabolite of the karlotoxin/amphidinol family
of compounds, a group of more than 40 structurally-related microalgae metabolites (Table S1).
Supplementary Materials: The following are available online at www.mdpi.com/1660-3397/15/9/278/s1.
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Calibration curve of fumonisin B1; Figure S5: Calibration curve of fumonisin B2; Figure S6: Strata-X prepared
sample with Bruker QTOF analysis; Table S1: Details of the amphidinol-like metabolites from dinoflagellates;
Table S2: Concentration of karmitoxin per cell.
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